Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Franck

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|August 7, 2021
Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literatureE Annabi, N Dupin, P Sohier, et al.
L'Encephale|December 20, 2014
[Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome]C Demily, M Rossi, M Schneider, et al.
Journal of the American Academy of Dermatology|September 1, 1995
Multicentric reticulohistiocytosis and methotrexateN Franck, B Amor, X Ayral, et al.
Journal of Clinical Immunology|May 1, 1997
An extract from cultured human keratinocytes that contains the major autoantigens related to autoimmune bullous skin diseasesF Batteux, N Franck, P Jaffray, et al.
L'Encephale|November 2, 2015
[How to improve practices and interventions for work integration of people with schizophrenia in France?]B Pachoud, P M Llorca, J M Azorin, et al.
The British Journal of Dermatology|December 23, 2016
Neutrophilic eccrine hidradenitis in two patients treated with BRAF inhibitors: a new cutaneous adverse eventF Herms, N Franck, N Kramkimel, et al.
The Journal of Rheumatology|August 1, 1993
Pulmonary hypertension in a case of dermatomyositisG Grateau, M E Roux, N Franck, et al.
Dermatology (Basel, Switzerland)|September 8, 2007
Epidermolysis bullosa acquisita following bullous pemphigoid, successfully treated with the anti-CD20 monoclonal antibody rituximabN Wallet-Faber, N Franck, F Batteux, et al.
Clinical and Experimental Dermatology|September 15, 2009
Morphoea (localized scleroderma): baseline body surface involvement and antinuclear antibody may have a prognostic valueE Alimova, D Farhi, F Plantier, et al.
Diabetologia|November 16, 2006
Peroxisome proliferator activated receptor gamma activity is low in mature primary human visceral adipocytesL Sauma, N Franck, J F Paulsson, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Journal of the European Academy of Dermatology and Venereology : JEADV|August 7, 2021
Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literatureE Annabi, N Dupin, P Sohier, et al.
L'Encephale|December 20, 2014
[Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome]C Demily, M Rossi, M Schneider, et al.
Journal of the American Academy of Dermatology|September 1, 1995
Multicentric reticulohistiocytosis and methotrexateN Franck, B Amor, X Ayral, et al.
Journal of Clinical Immunology|May 1, 1997
An extract from cultured human keratinocytes that contains the major autoantigens related to autoimmune bullous skin diseasesF Batteux, N Franck, P Jaffray, et al.
L'Encephale|November 2, 2015
[How to improve practices and interventions for work integration of people with schizophrenia in France?]B Pachoud, P M Llorca, J M Azorin, et al.
The British Journal of Dermatology|December 23, 2016
Neutrophilic eccrine hidradenitis in two patients treated with BRAF inhibitors: a new cutaneous adverse eventF Herms, N Franck, N Kramkimel, et al.
The Journal of Rheumatology|August 1, 1993
Pulmonary hypertension in a case of dermatomyositisG Grateau, M E Roux, N Franck, et al.
Dermatology (Basel, Switzerland)|September 8, 2007
Epidermolysis bullosa acquisita following bullous pemphigoid, successfully treated with the anti-CD20 monoclonal antibody rituximabN Wallet-Faber, N Franck, F Batteux, et al.
Clinical and Experimental Dermatology|September 15, 2009
Morphoea (localized scleroderma): baseline body surface involvement and antinuclear antibody may have a prognostic valueE Alimova, D Farhi, F Plantier, et al.
Diabetologia|November 16, 2006
Peroxisome proliferator activated receptor gamma activity is low in mature primary human visceral adipocytesL Sauma, N Franck, J F Paulsson, et al.
Pageof 9